Latest Insider Transactions at Nu Skin Enterprises, Inc. (NUS)
This section provides a real-time view of insider transactions for Nu Skin Enterprises, Inc. (NUS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of NU SKIN ENTERPRISES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of NU SKIN ENTERPRISES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 25
2023
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.3%
|
$56,000
$28.99 P/Share
|
|
Jun 26
2023
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.19%
|
$64,000
$32.12 P/Share
|
|
Jun 12
2023
|
Emma S. Battle Director |
BUY
Small Acquisition
|
Direct |
52
+0.67%
|
$1,820
$35.32 P/Share
|
|
Jun 07
2023
|
Pisano R. Thomas Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,232
+6.5%
|
-
|
|
Jun 07
2023
|
Zheqing Shen Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,232
+16.22%
|
-
|
|
Jun 07
2023
|
Edwina D Woodbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,249
+8.89%
|
$72,233
$17.73 P/Share
|
|
Jun 07
2023
|
Laura Nathanson Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,232
+20.54%
|
-
|
|
Jun 07
2023
|
Andrew D Lipman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,232
+6.33%
|
-
|
|
Jun 07
2023
|
Emma S. Battle Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,232
+32.25%
|
-
|
|
Jun 07
2023
|
Daniel W Campbell Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,232
+18.28%
|
-
|
|
Jun 05
2023
|
Chayce David Clark EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
979
-0.97%
|
$32,307
$33.74 P/Share
|
|
Jun 05
2023
|
Steven Keith Hatchett Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
462
-0.79%
|
$15,246
$33.74 P/Share
|
|
May 25
2023
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.31%
|
$68,000
$34.28 P/Share
|
|
May 09
2023
|
Edwina D Woodbury Director |
SELL
Open market or private sale
|
Direct |
1,255
-7.5%
|
$46,435
$37.87 P/Share
|
|
Apr 25
2023
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.21%
|
$80,000
$40.75 P/Share
|
|
Apr 21
2023
|
Connie Mang Yee Tang Chief Global Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,120
-2.53%
|
$45,920
$41.37 P/Share
|
|
Mar 31
2023
|
James D Thomas Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,360
+20.75%
|
-
|
|
Mar 27
2023
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.11%
|
$78,000
$39.29 P/Share
|
|
Mar 13
2023
|
Emma S. Battle Director |
BUY
Small Acquisition
|
Direct |
15
+0.19%
|
$600
$40.0 P/Share
|
|
Mar 09
2023
|
Steven Keith Hatchett Chief Product Officer |
SELL
Open market or private sale
|
Direct |
21,155
-26.6%
|
$825,045
$39.78 P/Share
|
|
Mar 09
2023
|
Steven Keith Hatchett Chief Product Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,155
+21.01%
|
$634,650
$30.45 P/Share
|
|
Mar 08
2023
|
Edwina D Woodbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.09%
|
$585
$39.74 P/Share
|
|
Mar 02
2023
|
Joseph Y Chang Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-54.07%
|
$1,000,000
$40.77 P/Share
|
|
Mar 02
2023
|
Joseph Y Chang Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+18.61%
|
$750,000
$30.54 P/Share
|
|
Mar 02
2023
|
Mark H Lawrence Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
26,144
-31.39%
|
$1,045,760
$40.8 P/Share
|
|
Mar 02
2023
|
Mark H Lawrence Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,041
+17.8%
|
$541,230
$30.45 P/Share
|
|
Mar 01
2023
|
Steven Lund Exec. Chairman of the Board |
SELL
Bona fide gift
|
Indirect |
9,050
-7.38%
|
-
|
|
Mar 01
2023
|
Joseph Y Chang Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
68,485
-76.33%
|
$2,739,400
$40.44 P/Share
|
|
Mar 01
2023
|
Joseph Y Chang Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,485
+43.29%
|
$2,054,550
$30.63 P/Share
|
|
Feb 28
2023
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.81%
|
$400,000
$40.68 P/Share
|
|
Feb 28
2023
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.3%
|
$300,000
$30.63 P/Share
|
|
Feb 27
2023
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
21,513
-11.31%
|
$882,033
$41.38 P/Share
|
|
Feb 27
2023
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,513
+10.16%
|
$645,390
$30.63 P/Share
|
|
Feb 23
2023
|
James D Thomas Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,829
-13.63%
|
$115,989
$41.12 P/Share
|
|
Feb 22
2023
|
Emma S. Battle Director |
SELL
Open market or private sale
|
Direct |
987
-17.48%
|
$40,467
$41.7 P/Share
|
|
Feb 22
2023
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.53%
|
$41,000
$41.42 P/Share
|
|
Feb 22
2023
|
Chayce David Clark EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
18,090
+15.14%
|
-
|
|
Feb 22
2023
|
Steven Keith Hatchett Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,251
+14.94%
|
-
|
|
Feb 22
2023
|
James D Thomas Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,330
+31.01%
|
-
|
|
Feb 22
2023
|
Mark H Lawrence Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,899
+23.37%
|
-
|
|
Feb 22
2023
|
Connie Mang Yee Tang Chief Global Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,507
+23.36%
|
-
|
|
Feb 22
2023
|
Ryan S Napierski President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
53,064
+23.92%
|
-
|
|
Feb 15
2023
|
James D Thomas Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,295
-10.18%
|
$58,275
$45.38 P/Share
|
|
Feb 15
2023
|
Joseph Y Chang Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,981
-8.53%
|
$89,145
$45.38 P/Share
|
|
Feb 15
2023
|
Chayce David Clark EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,303
-1.54%
|
$58,635
$45.38 P/Share
|
|
Feb 15
2023
|
Steven Keith Hatchett Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,314
-2.66%
|
$59,130
$45.38 P/Share
|
|
Feb 15
2023
|
Connie Mang Yee Tang Chief Global Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
870
-2.75%
|
$39,150
$45.38 P/Share
|
|
Feb 15
2023
|
Mark H Lawrence Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,868
-5.95%
|
$129,060
$45.38 P/Share
|
|
Feb 15
2023
|
Ryan S Napierski President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,963
-5.68%
|
$313,335
$45.38 P/Share
|
|
Jan 23
2023
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.51%
|
$42,000
$42.27 P/Share
|